Figure 5From: Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanomaExpression of CD83 (left) and CD86 (right) by patients' RNA-transfected DCs (red) used for vaccination. Isotype controls are shown in green.Back to article page